|
1
|
Archer SL, Weir EK and Wilkins MR: Basic
science of pulmonary arterial hypertension for clinicians: New
concepts and experimental therapies. Circulation. 121:2045–2066.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakata TM, Tanaka R, Yoshiyuki R, Fukayama
T, Goya S and Fukushima R: Effects of single drug and combined
short-term administration of sildenafil, pimobendan, and nicorandil
on right ventricular function in rats with monocrotaline-induced
pulmonary hypertension. J Cardiovasc Pharmacol. 65:640–648. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rabinovitch M, Guignabert C, Humbert M and
Nicolls MR: Inflammation and immunity in the pathogenesis of
pulmonary arterial hypertension. Circ Res. 115:165–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmed LA, Obaid AA, Zaki HF and Agha AM:
Role of oxidative stress, inflammation, nitric oxide and
transforming growth factor-beta in the protective effect of
diosgenin in monocrotaline-induced pulmonary hypertension in rats.
Eur J Pharmacol. 740:379–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
White RJ and Morrell NW: Understanding the
low penetrance of bone morphogenetic protein receptor 2 gene
mutations: Another needle in the haystack. Circulation.
126:1818–1820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sutendra G, Dromparis P, Bonnet S, Haromy
A, McMurtry MS, Bleackley RC and Michelakis ED: Pyruvate
dehydrogenase inhibition by the inflammatory cytokine TNFα
contributes to the pathogenesis of pulmonary arterial hypertension.
J Mol Med (Berl). 89:771–783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hassoun PM, Mouthon L, Barberà JA,
Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML,
Michelakis ED, Morrell NW, et al: Inflammation, growth factors, and
pulmonary vascular remodeling. J Am Coll Cardiol. 54:(1 Suppl).
S10–S19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sen R and Baltimore D: Inducibility of
kappa immunoglobulin enhancer-binding protein Nf-kappa B by a
posttranslational mechanism. Cell. 47:921–928. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimura H, Okada O, Tanabe N, Tanaka Y,
Terai M, Takiguchi Y, Masuda M, Nakajima N, Hiroshima K, Inadera H,
et al: Plasma monocyte chemoattractant protein-1 and pulmonary
vascular resistance in chronic thromboembolic pulmonary
hypertension. Am J Respir Crit Care Med. 164:319–324. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hoeper MM, Schwarze M, Ehlerding S,
Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M and
Fabel H: Long-term treatment of primary pulmonary hypertension with
aerosolized iloprost, a prostacyclin analogue. N Engl J Med.
342:1866–1870. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilkins MR, Ali O, Bradlow W, Wharton J,
Taegtmeyer A, Rhodes CJ, Ghofrani HA, Howard L, Nihoyannopoulos P,
Mohiaddin RH, et al: Simvastatin as a treatment for pulmonary
hypertension trial. Am J Resp Crit Care Med. 181:1106–1113. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galié N, Ghofrani HA, Torbicki A, Barst
RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A,
et al: Sildenafil citrate therapy for pulmonary arterial
hypertension. N Engl J Med. 353:2148–2157. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Benza RL, Miller DP, Barst RJ, Badesch DB,
Frost AE and McGoon MD: An evaluation of long term survival from
time of diagnosis in pulmonary arterial hypertension from the
REVEAL Registry. Chest. 142:448–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang ZR, Leung WN, Cheung HY and Chan CW:
Osthole: A review on its bioactivities, pharmacological properties,
and potential as alternative medicine. Evid Based Complement
Alternat Med. 2015:9196162015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liao PC, Chien SC, Ho CL, Wang EI, Lee SC,
Kuo YH, Jeyashoke N, Chen J, Dong WC, Chao LK and Hua KF: Osthole
regulates inflammatory mediator expression through modulating
NF-κB, mitogen-activated protein kinases, protein kinase C, and
reactive oxygen species. J Agric Food Chem. 58:10445–10451. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang XP, Chen XM, Cui QH and Tian JZ:
Studies on pharmacological activity and mechanism of osthole. China
Licensed Pharmacist. 11:28–32. 2013.
|
|
17
|
You L, Feng S, An R and Wang X: Osthole: A
promising lead compound for drug discovery from a traditional
Chinese medicine (TCM). Nat Prod Commun. 4:297–302. 2009.PubMed/NCBI
|
|
18
|
Wang R, Kong J, Wang D, Lien LL and Lien
EJ: A survey of Chinese herbal ingredients with liver protection
activities. Chin Med. 2:52007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z, Ji H, Song X, Hu J, Han N and Chen
N: Osthole attenuates the development of carrageenan-induced lung
inflammation in rats. Int Immunopharmacol. 20:33–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng Y, Lu M, Ma L, Zhang S, Qiu M and Ma
X: Osthole ameliorates renal ischemia-reperfusion injury by
inhibiting inflammatory response. Urol Int. 91:350–356. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Blenes SB, Fischer S, McIntyre B,
Keshavjee S and Rabinovitch M: Hemodynamic unloading leads to
regression of pulmonary vascular disease in rats. J Thorac
Cardiovasc Surg. 121:279–289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nogueira-Ferreira R, Vitorino R, Ferreira
R and Henriques-Coelho T: Exploring the monocrotaline animal model
for the study of pulmonary arterial hypertension: A network
approach. Pulm Pharmacol Ther. 35:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campian ME, Hardziyenka M, Michel MC and
Tan HL: How valid are animal models to evaluate treatments for
pulmonary hypertension? Naunyn Schmiedebergs Arch Pharmacol.
373:391–400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishimura T, Faul JL, Berry GJ, Veve I,
Pearl RG and Kao PN: 40-O-(2-hydroxyethyl)-rapamycin attenuates
pulmonary arterial hypertension and neointimal formation in rats.
Am J Respir Crit Care Med. 163:498–502. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rey M, Hess P and Clozel M:
Monocrotaline-induced pulmonary hypertension in Wistar rats. Curr
Protoc Pharmacol Chapter. 5:Unit 5.56. 2009. View Article : Google Scholar
|
|
26
|
Liu C, Fang C, Cao G, Liu K, Wang B, Wan
Z, Li S and Wu S: Ethyl pyruvate ameliorates monocrotaline-induced
pulmonary arterial hypertension in rats. J Cardiovasc Pharmacol.
64:7–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Wang Y, Rong S and Ma H: Early
treatment with hepatocyte growth factor improves pulmonary artery
and right ventricular remodeling in rats with pulmonary artery
hypertension by modulating cytokines expression. Zhonghua Jie He He
Hu Xi Za Zhi. 37:427–432. 2014.(In Chinese). PubMed/NCBI
|
|
28
|
Liu ZQ, Liu B, Yu L, Wang XQ, Wang J and
Liu HM: Effect of simvastatin on expression of cyclooxygenase-2 in
a rat model of pulmonary artery hypertension. Chin Heart J.
21:625–628. 2009.
|
|
29
|
Lee TL, Yeh J, Friedman J, Yan B, Yang X,
Yeh NT, Van Waes C and Chen Z: A signal network involving
coactivated NF-kappaB and STAT3 and altered p53 modulates
BAX/BCL-XL expression and promotes cell survival of head and neck
squamous cell carcinomas. Int J Cancer. 122:1987–1998. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoffmann A, Levchenko A, Scott ML and
Baltimore D: The IkappaB-NF-kappa B signaling module: Temporal
control and selective gene activation. Science. 298:1241–1245.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ogawa A, Firth AL, Yao W, Rubin LJ and
Yuan JX: Prednisolone inhibits PDGF-induced nuclear translocation
of NF-kappaB in human pulmonary artery smooth muscle cells. Am J
Physiol Lung Cell Mol Physiol. 295:L648–L657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang XL, Shang X, Cui Y, Zhao X, Zhang Y
and Xie ML: Osthole inhibits inflammatory cytokine release through
PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes.
Immunopharmacol Immunotoxicol. 37:185–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
